Target intelligence / Profile preview

Hemocyanin (Hc)

Target
Hc
Molecular classification
Copper-binding protein, Oxygen transport protein, Type-3 copper protein
01

Overview

Hemocyanins are large, multi-subunit, copper-containing proteins that facilitate oxygen transport in the hemolymph of various invertebrates, including mollusks and arthropods (Source: UniProt). Unlike the iron-based hemoglobin found in vertebrates, hemocyanins utilize two copper atoms to reversibly bind a single oxygen molecule, resulting in a blue coloration when oxygenated (Source: Wikipedia). In clinical medicine, Keyhole Limpet Hemocyanin (KLH), derived from the marine gastropod Megathura crenulata, is utilized as a powerful immunostimulant and vaccine carrier (Source: PubChem). It is highly effective as a treatment for superficial bladder cancer and serves as a standard carrier protein for haptens in immunological research and vaccine development due to its ability to elicit a robust T-cell dependent immune response (Source: PubMed). Its therapeutic utility stems from its high molecular weight and foreign nature, which makes it one of the most immunogenic proteins known (Source: StatPearls). Furthermore, hemocyanins are being investigated for their potential anti-tumor properties and as diagnostic tools to assess immune competence in patients (Source: NIH).

Other names
Keyhole limpet hemocyaninKLHMolluscan hemocyaninArthropod hemocyaninMegathura crenulata hemocyaninCopper-based oxygen carrier
02

Mechanism of action

Hemocyanin, particularly Keyhole Limpet Hemocyanin (KLH), acts as a potent foreign antigen that stimulates a robust Th1-type cellular immune response and antibody production. In the treatment of bladder cancer, it induces a local inflammatory response and recruitment of cytotoxic T cells to the tumor site (Source: PubMed, PMID: 11563487).

03

Biological functions

Oxygen transportImmune response stimulationPhenoloxidase activity
04

Disease associations

Bladder cancerInfectionCancer immunotherapy
05

Safety considerations

Hypersensitivity reactionsAnaphylaxisInjection site inflammationFever and flu-like symptoms
06

Interacting drugs

Keyhole limpet hemocyanin

1 more in the full profile.

07

Biomarkers

Anti-KLH antibody titersDelayed-type hypersensitivity (DTH) skin test response

Beyond the preview

Go deeper on Hemocyanin (Hc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemocyanin (Hc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call